Canada Markets open in 4 hrs 13 mins

BriaCell Therapeutics Corp. (BCT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
6.31-0.41 (-6.10%)
At close: 3:54PM EDT
Full screen
Previous Close6.72
Open6.78
Bid6.44 x 0
Ask6.48 x 0
Day's Range6.24 - 7.69
52 Week Range3.50 - 10.76
Volume38,464
Avg. Volume17,922
Market Cap42.256M
Beta (5Y Monthly)1.59
PE Ratio (TTM)N/A
EPS (TTM)-3.10
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • BriaCell Phase I/IIa Clinical Trial Combination Study in Advanced Breast Cancer Patients Open for Enrollment
    GlobeNewswire

    BriaCell Phase I/IIa Clinical Trial Combination Study in Advanced Breast Cancer Patients Open for Enrollment

    NEW YORK and VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, today announces the open recruitment and enrollment of their collaborative clinical study with Incyte. The Phase I/IIa combination study is designed to evaluate BriaCell’s lead candidate, Bria-IMT™, with I

  • BriaCell to Present at Three Upcoming Investor Conferences
    GlobeNewswire

    BriaCell to Present at Three Upcoming Investor Conferences

    BERKELEY, Calif. and VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, today announced that Dr. William V. Williams, President & CEO of BriaCell, is scheduled to present in the following virtual conferences: Access to Giving Virtual Investor conference: July 13 – 15,

  • ACCESSWIRE

    50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

    RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th \- 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event.